SPDR MSCI USA Gender Diversity ETF (SHE) 옵션

We trust your beliefs Filter! Good luck to us all!!!

That would be one hellava great "job" to have. I envy your position. Me yes a Sax Man as well as Piano player. I had a really rough job in Uncle's Army back in the 60's. Sax player Army Bands. Only a couple years. Retired 26 years ago... Winter in Florida is a wonderful place to attend all sorts of

Please look at the graph at this link and then tell me your post was only one-half BS.

https://www.factcheck.org/2025/01/illegal-immigration-and-fentanyl-at-the-u-s-northern-and-southwest-borders/

made with AI-------

$CBLO~~~~>> Sitting pretty at $0.01 with 1.4M shares traded and every last one a BUY. No sellers. Just quiet loading.

With a 14MW crypto mining facility, CoinEdge JV, and Cardano exposure, this one’s a ticking time bomb. Low float + real catalysts = serious potential.

E

https://fintel.io/ss/us/muln

$CBLO~~~~>> Sitting pretty at $0.01 with 1.4M shares traded and every last one a BUY. No sellers. Just quiet loading.

With a 14MW crypto mining facility, CoinEdge JV, and Cardano exposure, this one’s a ticking time bomb. Low float + real catalysts = serious potential.

E

Thankfully, I was able to pick up more 4s Wednesday. Exciting times my friend.

$ANIX Breakthrough breast cancer vaccine stops tumors before they start
A new breast cancer vaccine shows strong immune responses and no major side effects in early trials, offering hope against TNBC.

https://www.thebrighterside.news/post/breakthrough-breast-cancer-vaccine-stop

Lots of Dem have it

This is the OTC!! Many people tell stories of Billionaires buying a shell!! It doesn't make sense!! Why not start from scratch?? These are questions you need to ask yourself!! Working hard is a character trait but it doesn't guarantee results!!

Here is our Warning To Buy All You Can And Hold As Much As You Can For Bigger Profits... TW*OH Was The First Run To Show Us How High These Plays Can Get If OTC Stick Together Like They Did in 2020 -2021.......OTC Drought Is Over!! Real Merger Plays and Real Tech Plays Will Lead the charge!! AFFU .0

Correction: she did of a rare brain condition not cancer.

Mr. Emil Assentato who is a honorably discharged Navy veteran has worked his tail off his entire life and made billions and I personally am blessed with the opportunity to be a part of this stock. If you don't want to take the opportunity that has been given to you that's your choice but  think this

The last otc stock i thought had potential like this one in the triple zero range would have given me a six figure profit but of course i sold too early .. imo this is stepping in the right direction... slowly but surely.. some others I follow are reassuring this for me!  Small investments at these

Fri,46k buys,11k sells,3k gray

DJ, we had almost double volume on Thursday and triple on Friday. Will see if average volume returns on Monday or not, I would like to see at minimum over 6 million and establish a new higher low consolidation area and move incrementally from there until approval.

Fantastic Friday close at .0049 holding every single share I could get my hands on and ready to see pennies 

Lucy Markovoch famous Australian Model died at age of 27 from a rare of brain cancer. How many have to die,? You mgs regulators are as bad as wallstreet criminals.

Combining CARTs targeting uPAR and HER2 + cetuximab. Interesting

Especially if it has been created

On purpose

Problem reaction solution Disease forecasts are like weather forecasts: We cannot predict the finer details of a particular outbreak or a particular storm, but we can often identify when these threats are emerging and prepare

Problem with CARNK, AUTO and ALLO is reduced FLU dose has shown subpar result in clearing long lived B cells in BM. NKTX is not looking for DORIS remission as goal. They are skipping FLU because rheumatologists don't want it. They know ALLO will be the better option if CARNK requires the same precon

They're doing a very good job on that stuff. They should do one featuring Linda McMahon, and send it to her.

She loves A1...

The collaboration and license agreement with Pfizer will terminate effective April 21, 2025, at which time Pfizer will be required to transition the giroctocogene fitelparvovec program back to Sangamo.